HIV Malignancy Specimens for Research at No Charge
On behalf of Toby T. Hecht, Ph.D. Associate Director, Translational Research Program, DCTD, NCI and Robert Yarchoan, M.D., Director, Office of HIV and AIDS Malignancy, NCI To the HIV Malignancy …
Drs. Elaine Jaffe, Louis Staudt and Robert Yarchoan at The National Institutes of Health recipients of Departmental Awards from the U.S. Department of Health and Human Services (HHS) for their groundbreaking research leading to …
We are thrilled to announce ACSR’s highly valued relationship with Proscia®. Read the full release below for more on how enterprise digital pathology thru Proscia Concentriq is helping the ACSR …
The ACSR shares the same goal as millions around the world—to end the HIV epidemic. It will take a global effort, and we remain committed to supporting HIV/AIDS malignancy research to …
On Jan. 28, 2003, President George W. Bush announced the establishment of The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) during the State of the Union Address, leveraging years …
New off the press by the ACSR’s Dr. Jeffrey Bethony and colleagues from George Washington University, Scripps Research, the Fred Hutchinson Cancer Center, the National Institutes of Health and other …
(From the CFAR Adelante RFA: https://cfar-adelante.org/wp-content/uploads/2022/08/Adelante.RFA-CohortV_FINAL-081522.pdf) As confirmed by the National Ending the HIV Epidemic in the U.S. (EHE) Initiative, there has been adearth of culturally responsive research specific to …
New from Dr. Lawrence Tablak, NIH Director, a hopeful post describing recent work that may move us a step closer to eliminating latent HIV infection and ultimately finding a cure …
Please join the Office of AIDS Research (OAR) for the NIH World AIDS Day Observance Tuesday, December 1, 2020, from 11:00 a.m. to 12:30 p.m. EST. This virtual event is …
The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best …